Michael B Andrews

9PUBLICATIONS
9CO-AUTHORS
Molecular targetsColloid and surface chemistryToxicology (incl. clinical toxicology)Occupational epidemiologyFood engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 15, 2026
A comprehensive analysis of the adverse drug events of metastatic and unresectable gastrointestinal stromal tumor treatment options: avapritinib, imatinib, regorafenib, ripretinib, and sunitinib safety insights and implications.

|Jun 23, 2025
Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Following Initiation of Sulfasalazine for Ulcerative Colitis: A Yearlong Clinical Challenge.

Michael B Andrews, Michael V Patrone, Stephen J Bickston

|Jun 12, 2025
Constipation-predominant irritable bowel syndrome treatment options Linaclotide, Lubiprostone, Plecanatide, and Tenapanor: analysis of the FDA Adverse Event Reporting System (FAERS) database.

Michael B Andrews, Douglas G Adler

|May 06, 2025
Dupilumab Use in Eosinophilic Esophagitis: Analysis of the FDA Adverse Event Reporting System Database.

Michael B Andrews, Hiba Khan, Douglas G Adler

|Apr 12, 2025
Comprehensive analysis of adverse drug reactions associated with teduglutide: post-marketing insights and safety implications.

Praneeth Kudaravalli, Michael B Andrews, Douglas G Adler

|Apr 11, 2025
Thyrotoxicosis-Induced Myopathic Dysphagia Treated With Plasmapheresis.

Michael B Andrews, Mary Stevenson, Puneet Puri

Pageof 2

Frequent Collaborators

5 joint publications

Douglas G Adler

1 joint publications

Manaswitha Thota

1 joint publications

Jonathan Van Name

1 joint publications

Tamas Gal